LifeVantage to Participate in the 28th Annual ICR Conference
LifeVantage (Nasdaq: LFVN) will participate in the 28th Annual ICR Conference in Orlando, FL, January 12-14, 2026.
Rhea-AI Summary
LifeVantage (Nasdaq: LFVN) will participate in the 28th Annual ICR Conference in Orlando, FL, January 12-14, 2026. CEO Steve Fife and CFO Carl Aure will present at approximately 1:00 p.m. ET on Monday, January 12, 2026. A live webcast of the presentation will be available on the company's Investor Relations News & Events page.
This provides investors and analysts access to company leadership commentary and a webcast replay option for those unable to attend live.
Positive
- None.
Negative
- None.
Details
News Market Reaction – LFVN
On Jan 7, the first trading day after this news, LFVN closed 0.48% above the previous close.
Data tracked by StockTitan Argus for the Jan 7 session.
Key Figures
- Share price
- $6.09
- Prior to ICR Conference participation announcement
- Market cap
- $76,588,158
- Before conference news
- Volume today
- 149,309 shares
- Trading day of the announcement
- 20-day avg volume
- 193,082 shares
- Pre-announcement average liquidity
- 52-week high
- $27.38
- Pre-announcement reference level
- 52-week low
- $5.69
- Pre-announcement reference level
- ICR Conference dates
- January 12–14, 2026
- 28th Annual ICR Conference schedule
- Presentation time
- 1:00 p.m. Eastern Time
- LFVN presentation on Monday, January 12, 2026
Historical Context
-
Announcement of CEO and CFO participation in Water Tower Fireside Chat.
-
In vitro P84 data showing strong changes in multiple gut peptides and proteins.
-
Board approval of a quarterly cash dividend of $0.045 per share.
-
Q1 FY26 results with revenue $47.6M and reiterated full-year guidance.
-
Momentum Academy 2025 event integrating LoveBiome and launching new products.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
nasdaq financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the 28th Annual ICR Conference to be held January 12-14, 2026 in Orlando, FL.
Mr. Fife and Mr. Aure will present at approximately 1:00 p.m. Eastern Time on Monday, January 12, 2026. A webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84. The robust portfolio also includes activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.